# HigoSense Sp. z o.o.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/higosense-sp-z-o-o

- Industry: Medical Devices & Equipment
- Headquarters: Warsaw, Poland
- Website: www.higosense.com
- Total disclosed funding: $5.6M
- Latest round: Series A (Dec 20, 2021)
- Investors on record: 1

## About

HigoSense Sp. z o.o. is a Polish company that specializes in telemedicine solutions, offering innovative medical devices for remote diagnostics and healthcare management.Founded in 2017 in Warsaw, Poland, HigoSense Sp. z o.o. focuses on telemedicine through its primary offering, the Higo® medical device. The company has secured EUR 5 million in Series A funding led by Cogito Capital Partners on December 20, 2021, raising its total funding to EUR 5 million. Lukasz Krasnopolski and Michal Biernat founded the company, with Krasnopolski serving as CEO.HigoSense Sp. z o.o. specializes in innovative telemedical solutions, primarily through its flagship product, the Higo® medical device. This device facilitates remote medical diagnoses by enabling users to perform comprehensive examinations using its five interchangeable modules: a thermometer, stethoscope, otoscope, dermhood, and throat spatula. The Higo® device empowers trained individuals, such as caregivers and medical staff, to conduct medical assessments in various settings, including elderly homes and private residences. The Higo App complements the device by providing patients with timely diagnoses and e-prescriptions, allowing them to manage their health data securely. HigoSense targets markets in Europe, North America, and Asia, focusing on direct consumers, healthcare providers, and institutions seeking to enhance their telemedicine capabilities.In 2023, HigoSense generated revenue amounting to EUR 729,977, with an EBITDA of EUR 174,014. Revenue is derived from direct sales of Higo® medical devices, subscriptions to the Higo App, and B2B transactions with healthcare facilities and elder care homes. The company also partners with medical institutions for remote patient monitoring and diagnostics, although specific pricing details are not disclosed.Following the Series A funding of EUR 5 million in December 2021, HigoSense plans to utilize the investment to expand its solutions into new markets across Europe, the Middle East, and Asia. The company is focused on enhancing its product offerings and is actively designing new functionalities for the Higo product line. HigoSense aims to establish a stronger presence in these regions by strategically targeting healthcare institutions and enhancing its telemedicine capabilities.

## Funding rounds

- Series A, Dec 20, 2021, $5.6M — Cogito Capital

## Investors

- Cogito Capital — Series A